Oncogenomics: Clinical pathogenesis approach

Oncogenomics is new research sub-field of genomics, which applies high throughput technologies to characterize genes associated with cancer and synonymous with cancer genomics. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of genetics (Navi Mumbai) 2009-12, Vol.1 (2), p.25-43
Hauptverfasser: G, Gupta, AK, Mujapara, A, Boraste, Y, Khairnar, KK, Vamsi, A, Jhadav, M, Gupta, P, Patil, S, Trivedi, N, Gupta, B, Joshi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Oncogenomics is new research sub-field of genomics, which applies high throughput technologies to characterize genes associated with cancer and synonymous with cancer genomics. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers, and new targets for cancer therapies. Oncoproteomics is the term used to describe the application of proteomic technologies in oncology and parallels the related field of oncogenomics. It is now contributing to the development of personalized management of cancer. Genomics has generated a wealth of data that is now being used to identify additional molecular alterations associated with cancer development. Mapping these alterations in the cancer genome is a critical first step in dissecting oncological pathways.
ISSN:0975-2862
0975-9158
DOI:10.9735/0975-2862.1.2.25-43